Canada markets closed

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.55+0.20 (+2.14%)
At close: 04:00PM EDT
9.55 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 524.42M
Enterprise Value 373.54M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.55
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.51

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3-25.97%
S&P500 52-Week Change 322.38%
52 Week High 316.90
52 Week Low 34.26
50-Day Moving Average 312.65
200-Day Moving Average 39.01

Share Statistics

Avg Vol (3 month) 31.04M
Avg Vol (10 day) 31.13M
Shares Outstanding 554.91M
Implied Shares Outstanding 654.91M
Float 836.14M
% Held by Insiders 10.49%
% Held by Institutions 185.96%
Shares Short (Apr 15, 2024) 45.05M
Short Ratio (Apr 15, 2024) 43.32
Short % of Float (Apr 15, 2024) 49.55%
Short % of Shares Outstanding (Apr 15, 2024) 49.19%
Shares Short (prior month Mar 15, 2024) 42.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 31, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Aug 20, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.47%
Return on Equity (ttm)-31.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-72.89M
Diluted EPS (ttm)-2.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)246.53M
Total Cash Per Share (mrq)4.49
Total Debt (mrq)329k
Total Debt/Equity (mrq)0.14%
Current Ratio (mrq)21.73
Book Value Per Share (mrq)3.60

Cash Flow Statement

Operating Cash Flow (ttm)-68.44M
Levered Free Cash Flow (ttm)-36.52M